Abstract-l. Salicylate actions on afferent nerve activity in the Xenopus lateral lme and on cochlear potentials in guinea pig were investigated.
INTRODUCTION
For at least a century, it has been recognized that aspirin (acetylsalicylic acid) can cause tinnitus and hearing loss. The effects are completely reversible, usually 24-72 hr after stopping aspirin ingestion (Macht et al., 1920; McCabe and Dey, 1965; Mongan et al., 1973) . The toxicity has been attributed to the salicylate ion since sodium salicylate produces a reversible increase in auditory threshold at concentrations comparable to those present in blood following the administration of aspirin (Myers and Bernstein, 1965; Gold and Wilpizeski, 1966; Silverstein et al., 1967) .
To date, the literature cannot explain the precise nature of the hearing loss due to salicylate although the cochlea appears to be the primary site of action . For example, Silverstein et al. (1967) reported that both the cochlear microphonic (CM) and the compound action potential of the auditory nerve (CAP) were depressed in cats following intraperitoneal injection of sodium salicylate. McPherson and Miller (1974) reported the same effect in guinea pigs following intragastric injection of choline salicylate. These results suggest that the hair cells of the cochlea are affected by salicylate. On the other hand, Mitchell et al. (1973) observed only the decrease in CAP following subcutaneous administration of sodium salicylate to guinea pigs and concluded that salicylate affected the auditory nerve and not the hair cells. The results of Thalmann et al. (1973) , Thalmann (1975) and Bobbin and Thompson (1978) which showed that fAuthor to whom correspondence should he addressed. salicylate reduced the CAP without affecting CM, support this conclusion.
The present study was designed to provide additional information about the effects of salicylate. We examined a hypothesis first suggested by Mitchell et al. (1973) that salicylate may have an action at the hair cell-afferent nerve synapse. Since L-glutamate appears to be the hair cell transmitter (Bledsoe et al., 1988) , we tested the effects of salicylate on responses to L-glutamate, spontaneous activity and water motion induced excitation of afferent nerve fibers innervating hair cells in the lateral line of Xenopus laeuis. For a comparison and to determine if the results obtained in the lateral line could possibly account for the actions of salicylate in the cochlea we also examined the effects of salicylate on guinea pig cochlear potentials looking for actions which could be explained by an antagonism of the action of the hair cell transmitter. A preliminary report has been presented (Bobbin et al., 1985~) .
MATERIALS AND METHODS
Lateral-line experiments were performed on adult male or female African clawed frogs, Xenopus laeris. The techniques for anesthetizing the animals, removing a portion of skin containing the lateral-line organ, the in vitro methods for isolating and recording afferent nerve activity from a single cluster of hair cells (stitch), and annlying drugs to the inner surface of the skin were as'previousiyhescribeed (Bledsoe and Bobbin. 1982 : Bledsoe et al.. 1983 : Bobbin er al.. 1985a . The posterior lateralis nerve trunk was dissected free from connective tissue and action potentials from the two afferent nerve fibers innervating a selected stitch were recorded extracellularly with a suction electrode, digitized and counted with a ratemeter in 30 set time bins. The inner surface of the skin was continuously washed with frog Artificial perilymph solutions were infused into the basal Ringer solution at room temperature (2G23"C) except turn Scala tympani and allowed to flow out of the basal turn during periods of drug testing. The Ringer solution, which scala vestibuli at approximately 0.6 pl/min for 10min flowed at a rate of 2 ml/min, had the following composition (mM): NaCl, 110; KCl, 2.0; CaCI,, 1.8; NaiHP6,.
2.25; through holes made in the cochlea. The composition of the artificial perilymph was similar to that used previously NaH,PO,. 0.75: DH. 7.0. The oreoaration described bv Bobgin e; al. (1481j was used' td study the effects o> (Bobbin and Ceasar, 1987) and had a composition of (mM): NaCI, 137; KCl, 5; CaCI,, 2; MgCl,, 1; Hepes, 1; glucose, salicylate on afferent nerve responses to glutamate and other 11; pH 7.4. The two drug solutions tested were sodium excitatory amino acids. Responses to agonists were obtained salicylate (salicylate) and for an osmotic control, alphaduring an initial drug-free Ringer wash, 40 min after starting ketoglutaqate.
The salicylate and alpha-ketoglutarate were a wash containing salicylate and again 20-30 min after initially dissolved in artificial perilymph to make a 20 mM washing the preparation with the drug-free Ringer solution. concentration and the pH adjusted to 7.4. Dilutions were For each response, 2 min of spontaneous activity were then made to yield concentrations tested (mM): 20, 10, 5, recorded, then a 1 ml volume of agonist solution with or 2.5, 1.25, 0.625, 0.312 and 0.156. In all animals, artificial without salicylate was injected into the tube delivering the perilymph without drug was the first perfusion. This was Ringer wash. The activity before drug application was used then followed by successive perfusions with increasing conto calculate a mean spontaneous firing rate. The difference centrations of the drug from 0.156 to 20 mM. All drug in the peak excitation elicited by an agonist and the pre-drug perfusions were followed by another 10 min perfusion with spontaneous level in the presence of salicylate was expressed artificial perilymph without drug. Intensity functions were as a percentage of that obtained in its absence.
obtained before and immediately (within 2 min) after each perfusion.
. The effects of sahcylate on water motion-induced responses of the afferent nerve fibers were evaluated as previously described (Bledsoe and Bobbin, 1982; Bobbin et al.. 1985a, b) . Isolated skins were held on the end of a plashc cylinder with a Neoprene O-ring and the external (cupular) surface of the skin facing down into a water-filled chamber. A glass rod attached to the cone of a loudspeaker was positIoned 0. Cochlear experiments were performed on 12 pigmented guinea pigs, Curia cobaya, of either sex using methods similar to those previously described (Bobbin and Ceasar, 1987 i.p.) to assure a deep level of anesthesia and rectal temperature was maintained at 37-39°C. The right cochlea of each animal was exposed ventrolaterally and both middle ear muscles sectioned.
The CAP (Nl -PI), Nl latency, CM and summating potential (SP) were recorded from a 200pm enamelinsulated silver wire placed m a hole m the Scala vestibuli of the basal turn, amplified, averaged (20 samples) and stored on a computer. The potentials were evoked by 10 kHz tone bursts having 0.25 msec exponential rise-fall times, 10 msec duration and 200 msec interstimulus interval. Intensity functions were obtained by varying tone burst intensities (2-104 dB SPL, in 6 dB steps). For measurement purposes, the stored voltages were directed into a filter with a low pass setting of 2 kHz for CAP, Nl latency and SP or a band pass of 7.1 to 15 kHz for CM, and the butput of the filter-was displayed on an oscilloscope.
The threshold of CAP was define; as the dB SPL needed to elicit a measurable response (2 5 pV) which increased in magnitude with the next step increase in sound intensity.
To quantify the effect of the salicylate, we carried out statistical tests on data obtained at: (1) a high sound intensity (98 dB SPL) before turnover of the CM potential, and (2) from a low intensity (62 dB SPL) which yielded potentials (CAP, Nl latency, CM and SP) after the drug treatment which were above the noisd of the recording system. Analysis of variance and Newmann-Keuls multiple range tests were used to determine significance (P < 0.01). The data are expressed as mean + SE.
RESULTS
In the lateral line salicylate blocked spontaneous activity and the increase in afferent nerve activity evoked by L-glutamate and kainic acid in a dose responsive manner ( Fig. 1 ; Table 1 ). The lowest concentration to have an antagonist effect was 0.30 mM whereas at 2.5 mM salicylate totally abolished spontaneous activity and the responses to glutamate and kainate. Water motion induced increases in afferent activity were more resistant to the blocking actions of salicylate. Salicylate at concentrations up to 1.25 mM reduced spontaneous activity without a marked suppressive effect on evoked activity ( Fig. 2 ; Table 2 ) whereas 2.5 mM abolished both spontaneous and evoked activity ( Fig. 2 ; Table 2 ). At 2.5 mM the effects of salicylate were partially reversible.
In the guinea pig cochlea the initial perfusion solution in each animal was artificial perilymph without drug. This perfusion produced a very small change in the cochlear potentials whereas subsequent perfusions with the same solution resulted in little additional change. Thus all drug effects are compared to potentials recorded after the first perfusion.
Artificial perilymph solutions containing salicylate induced a dose response suppression of the sound evoked CAP, increased Nl latency at a given low intensity and did not affect CM or SP (Figs 3 and 4) . The only significant change on CAP threshold with alpha-ketoglutarate occurred at 20 mM whereas with salicylate the CAP threshold was raised significantly beginning at concentrations of 0.6mM (Table 3 ). In addition, the Nl latency at the CAP threshold was significantly decreased by salicylate but not by alpha-ketoglutarate (Table 3 ). The effect of salicylate on CAP threshold responses was obtained by subtracting the threshold change produced by after washing the preparation with salicylate, and again 30min after a drug-free Ringer wash. An initial 30sec of spontaneous activity followed by three alternating 30 set periods of stimulated and spontaneous activity were recorded in 10 set time bins. Stimulus intensity was 9 dB re threshold.
alpha-ketoglutarate from the change produced by salicylate (Table 3 ). The data in Table 3 reveal the maximum effect of salicylate occurred at about 5 mM.
Statistical examination revealed that salicylate significantly reduced the magnitude of the CAP evoked by low intensity tone bursts (62dB SPL) in concentrations beginning at 1.25 mM (Fig. 4) . However, salicylate had no effect on CAP magnitude evoked by high-intensity tone bursts (98 dB SPL, not shown but see Fig. 3 ). In comparison alpha-ketoglutarate which only affected CAP at 20 mM, reduced responses to both low (Table 3 ) and high intensity tone bursts. Nl latency at a given low sound intensity (62 db SPL) was significantly increased by salicylate beginning at 2.5 mM (Fig. 4) . Consistent with the CAP amplitude data, Nl latency at a given high intensity (98 dB SPL) was not affected by salicylate (not shown but see Fig. 3 ). The control, alphaketoglutarate, did not affect Nl latency (Fig. 4) . The SP to low intensity tone bursts (62 dB SPL) was significantly reduced by high concentrations of both salicylate (10 and 20 mM) and alpha-ketoglutarate (20 mM) (Fig. 4) . In contrast, neither salicylate nor alpha-ketoglutarate significantly changed SP evoked by high-intensity (98 dB SPL) sound. The CM to both low-(62 dB SPL; Fig. 4 ) and high-(98 dB SPL) intensity tone bursts was not significantly altered by either salicylate or alpha-ketoglutarate. All these changes exhibited a partial recovery after a final perfusion with artificial perilymph without drug (Fig. 4) .
In two animals recovery was examined after a single perfusion of 5 mM salicylate. In both animals the salicylate induced a suppression of the CAP similar to that obtained with 5 mM salicylate in the cumulative salicylate paradigm. Subsequent perfusion of artificial perilymph induced a complete recovery of the CAP.
DISCUSSION
In the lateral line salicylate suppressed spontaneous activity and responses to L-glutamate and kainate in a dose responsive manner. In higher concentrations, yet at the same concentration that was required to completely block L-glutamate and kainate, salicylate antagonized the effect of natural stimulation (i.e. water motion). These results support the hypothesis that salicylate antagonizes the hair cell transmitter. The observation that higher concentrations of salicylate were necessary to block natural stimulation than was necessary to antagonize the effects of exogenously applied L-glutamate is common in the study of neurotransmitter antagonists (Davies et al., 1984 (Davies et al., , 1986 . On the other hand, this could indicate that the effect of salicylate was due to a nonselective mechanism such as blockade of an ion channel. Unfortunately, we could not test the selectivity of the glutamate block since other excitatory substances in the lateral line either act on L-glutamate receptors or on acetylcholine receptors, the latter which appear to act through the release of L-glutamate, the putative hair cell transmitter (Bobbin et al., 1985b) .
Cochlear perfusion of salicylate resulted in a dose responsive suppression of CAP and an increase in Nl latency which were not observed with the same concentrations of alpha-ketoglutarate. This indicates that the actions of salicylate were not due to nonspecific physical alterations in the cochlea such as might be brought about by osmotic effects. In addition, the concentrations of salicylate found effective on both the lateral line and cochlea are the (4); 2.5 mM (5); 5 mM (6); 10 mM (7); 20 mM (8), and a post drug artificial perilymph (R).
Asterisks indicate a statistically (P -c 0.01) significant difference from the value obtained after perfusion with artificial perilymph alone before drug (A). 'Numbers represent the dB values (mean + SE) obtained by subtracting the mean CAP threshold after each treatment from the mean CAP threshold after the predrug artificml perilymph perfusion (art. peri.; n = 5 except for 20 mM control where n = 4). tNumber represent the NI latency values (mean + SE) measured at CAP threshold after each treatment (n = 5 except for 20 mM control where n = 4). fControl dB values subtracted from sahcylate dB values to arrive at the effect of salicylate without apparent non-selective effects. §Indlcate a statlstlcally (P < 0.01) sigmficant difference from the value obtamed for artificial @lymph (art.
peri.) or 0.15 mM of drug.
same as the concentrations found in the cochlea after systemic administration of aspirin to achieve a blood level necessary to produce a hearing loss Thalmann, 1988) .
The slight changes in SP and CM were produced by both chemicals only at 10 and 20 mM indicating nonspecific osmotic effects at high concentrations as reported earlier with alpha-ketoglutarate (Jenison et al., 1986). The results on SP and CM are consistent with the lack of effect of salicylate on CM reported by Mitchell et al. (1973) , Thalmann et al. (1973) and Thalmann (1975) , but are inconsistent with the reduction in CM reported by Silverstein et al. (1967) . The SP and CM emanate from hair cells (Dallos, 1985a (Dallos, , b 1986 ) and reflect the state of these presynaptic elements. The lack of effect of salicylate on SP and CM at low concentrations (less than 10 mM) indicates a postsynaptic site of action.
The lack of effect on SP and CM is also consistent with salicylate not affecting the endocochlear potential since a change in the endocochlear potential would be expected to decrease CM and SP (Bobbin and Kisiel, 1981) . Thalmann et al. (1973) and Thalmann (1975) first showed that salicylate did not affect the endocochlear potential. In addition, they were the first to point out that one of the proposed mechanisms of action of salicylate in other systems-an interference with energy metabolism (Ferreira and Vane, 1974would not explain the action of salicylate in the cochlea because one of the most sensitive cochlear structures to antimetabolites is the stria vascularis and the endocochlear potential it generates. For example, dinitrophenol (DNP) perfused into the cochlea produces rapid reduction in the endocochlear potential and CM with a concomitant reduction in the CAP (Thalmann et al., 1973; Thalmann, 1975 ). Therefore we concur with Thalmann and conclude that one can exclude an action on energy metabolism as a mechanism of action for salicylate in the cochlea.
One result obtained in the guinea pig cochlea appears to argue against the hypothesis that salicylate antagonizes the hair cell transmitter in this organ. Our data show that salicylate disrupts the normal two slope pattern of the CAP input-output function: abolishing the segment to low intensity sounds with no effect on the higher intensity segment. The results are consistent with the observations of Thalmann (1975) who reported similar changes in the shape of the CAP input-output function with intraperitoneal injection of 350 mg/kg of salicylate. They contrast, however, with those obtained with kynurenic acid, a glutamate antagonist. Kynurenic acid perfused through the guinea pig cochlea reduces CAP amplitude at all sound intensities resulting in a parallel shift in the CAP input-output function (Bobbin and Ceasar, 1987) . A parallel shift is consistent with an antagonism of the hair cell transmitter since one would predict that the transmitter would be antagonized at all sound levels. This difference between the affects of salicylate and kynurenic acid on the CAP input-utput curve then leads us to question whether salicylate in the cochlea antagonizes the hair cell transmitter, and suggests that we search for an alternative explanation for the mechanism of action for salicylate in the cochlea.
Traditionally the CAP to low-intensity sounds in the cochlea which salicylate abolished has been described as the most sensitive portion of the CAP input-output curve since it is the first part of the curve suppressed by intense sound (Salt et al., 1981) and toxic substances (Aran, 1981; Dallos, 1973) . Most evidence indicates that the low intensity CAP reflects the summed activity of single afferent fibers firing at their most sensitive regions to sound stimulation. This region is known as the tip or nonlinear portion of the single afferent fiber tuning curve (Ozdamar and Dallos, 1976) . Like the low intensity portion of the CAP curve, the nonlinear portion of the single unit tuning curve is also more sensitive to drugs (Evans and Klinke, 1974) , anoxia (Evans, 1974) and intense sound (Cody and Johnstone, 1981) . In a study of salicylate on single afferent fiber activity, Evans et al. (1981) and Evans and Borerwe (1982) reported systematic changes in the characteristics of three primary fibers recorded from three cats following intravenous injection of sodium salicylate. They observed about a 25 dB loss in sensitivity at the characteristic frequencies accompanied by a gradual loss of sharpness in the tip of the tuning curves. Thus the action of salicylate at the level of the CAP and at the level of the single afferent nerve fiber is the same: abolishment of the low intensity portion of the CAP input-output function and abolishment of the single nerve tuning at low intensity. Recently it has been hypothesized that the nonlinear portion of the tuning curves and so the low intensity portion of the CAP input&output function reflect an active process (cochlear amplifier) within the cochlea which is required for achieving its sensitivity and frequency selectivity (Davis, 1983; Kim, 1986) . Thus it appears to us that in the cochlea the mechanism of action of salicylate involves an action on the active process iteself through an unknown molecular mechanism (e.g. prostaglandin synthesis) or to somehow interfere with its expression at the level of the nerve fibers. Other observations are consistent with this hypothesis. Aspirin consumption in humans and animals reduces delayed evoked otoacoustic emissions (Long et al., 1986; Martin et al., 1988) and reversibly eliminates spontaneous emissions (McFadden and Plattsmeir, 1984; Martin et al., 1988 ) which appear to depend on an intact active process in the cochlea. Since there is no evidence for an active process in the lateral line it is reasonable that no such action was detected in the lateral line. In addition, it is possible that in the cochlea the active process is more sensitive to salicylate than the hair cell transmitter. Along these lines the active process is thought to be located with the outer hair cells and diffusion of salicylate to this site would seem to be more easily achieved than diffusion to the hair cell transmitter receptor located at the base of the inner hair cells. If this is the case and we could investigate higher concentrations of salicylate, possibly by increasing the perfusion rate, we predict that a kynurenic acid-like action would be observed (i.e. a reduction in both the high and low intensity CAP) which would indicate an action on the hair cell transmitter. Future experiments will explore this possibility.
The increase in Nl latency with salicylate has not been reported previously and was characterized by a shift towards higher intensity at low intensity tone bursts in the latency/intensity function, no change in the Nl latency of CAP evoked by high intensity tone bursts and a shortening of Nl latency at the CAP threshold. We propose that as with our results with the CAP magnitude, all of these changes in Nl latency are consistent with increasing amounts of salicylate decreasing and eventually abolishing the active process or the cochlear amplifier (Davis 1983; Kim, 1986 ). Davis's model (1983) states that in the normal condition the ". . prolongation of latency near threshold beyond what can be explained by the rise time of the stimulus and the traveling wave delay . . ." is due to the extra time required for the cochlear amplifier resonator ". . . to build up to a full amplitude . .". In addition, he implies that as sound intensity increases the latency becomes shorter, in part due to the major site of cochlear partition motion and so nerve fiber activation shifting basalward on the partition from the site of the cochlear amplifier and a dependence on the cochlear amplifier towards a dependence on the passive traveling wave with its shorter latency. Therefore, it appears that the shorter Nl latency at CAP threshold observed after high concentrations of salicylate are consistent with salicylate having abolished the cochlear amplifier of Davis's model, and so abolishing the prolonged latency occurring at threshold which reflects the latency time required by the resonator of the cochlear amplifier. The fact that Nl latency at CAP threshold changes only slightly or not at all at low concentrations of salicylate can be explained by salicylate only suppressing the cochlear amplifier and so leaving it partially operative. In contrast, the salicylate induced longer Nl latency at a given low intensity or the shift towards higher intensity of the latencyintensity function at low intensity (Fig. 3) is difficult to explain at the present time. When this latency phenomena was observed after intense sound exposure, we hypothesized that the abolishment of the cochlear amplifier slowed the rate of travel of the traveling wave . We speculate that this also explains the present phenomena observed after salicylate. The lack of effect of high concentrations of salicylate on the Nl latency evoked by high intensity tone bursts is consistent with: (1) the dominance, at high intensity, of the passive traveling wave over the cochlear amplifier which according to the Davis model saturates at about 45 dB above threshold and, (2) a lack of effect of salicylate on the passive traveling wave and all the cochlear functions associated with it. Thus it appears that in the cochlea all of the actions of salicylate can be explained by an action on the active process or cochlear amplifier of Davis or an action which somehow interferes with its expression at the level of the nerve fibers or the CAP and Nl latency.
In summary, in the lateral line salicylate suppresses spontaneous afferent fiber activity, water motion (natural) evoked activity and the action of L-glutamate and kainate. In the guinea pig, salicylate reversibly suppresses CAP and increases Nl latency at low but not high sound intensities without a detectable affect on CM and SP. We conclude that the mechanism for this action of salicylate may be different in the two animals. In the lateral line the drug may act on the afferent nerve to antagonize the action of the afferent transmitter. In the guinea pig the drug appears to affect the active process and not the afferent transmitter. Whether higher concentrations of salicylate in the guinea pig will produce an effect which resembles that of hair cell transmitter antagonists will be tested in future experiments.
